Free Trial

Immunome (IMNM) SEC Filings & 10K Form

$12.09
-0.25 (-2.03%)
(As of 10/17/2024 ET)

Recent Immunome SEC Filings

DateFilerForm TypeView
10/08/2024
3:31 PM
Immunome (Filer)
Form S-3ASR
10/07/2024
6:14 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
6:26 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
1:18 PM
Immunome (Subject)
Rosett Max (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
8:05 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
8:07 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
2:21 PM
Higgins Jack (Reporting)
Immunome (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:48 PM
Immunome (Issuer)
Turner Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:51 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:54 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:56 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:36 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:40 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:43 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:10 PM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/18/2024
7:52 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:54 PM
Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:56 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:59 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:01 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:05 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2024
8:08 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:48 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:49 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:13 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:11 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
7:48 AM
Immunome (Filer)
Form 424B5
05/14/2024
7:05 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
7:02 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
7:14 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:12 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/26/2024
3:12 PM
Immunome (Filer)
Form ARS
04/25/2024
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
3:40 PM
Immunome (Filer)
Form S-3ASR
03/28/2024
3:04 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:06 PM
Immunome (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
8:07 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2024
8:10 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
1:10 PM
Alpine Global Management, LLC (Filed by)
Immunome (Subject)
Form SC 13G/A
I want to be very real with you (Ad)

Listen, I don’t come at my readers this direct very often, but here goes nothing: There is one strategy that has helped change my life and I’d like to think it has changed the lives of some of my readers, too. We’ve had success stories but I won’t even show you here because I don’t want you to get unrealistic expectations since individual results do vary. But the point is, this thing is the real deal. There’s a reason I consider it my flagship, even with all the market advantages I’ve discovered in recent years.

02/06/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
8:18 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
7:50 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
7:53 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:27 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:33 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/04/2024
4:37 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:40 PM
Immunome (Issuer)
Lapetina Bob (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:00 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
7:35 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
6:24 PM
Immunome (Issuer)
Roberts Phil Noland (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/15/2023
6:28 PM
Immunome (Issuer)
Roberts Phil Noland (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:08 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
11:15 PM
Immunome (Filer)
Form EFFECT
11/15/2023
5:03 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:52 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:23 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/09/2023
3:25 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
7:00 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
7:30 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2023
5:30 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:32 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:35 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2023
3:12 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMNM) was last updated on 10/17/2024 by MarketBeat.com Staff
From Our Partners